SOR III GRPA Data Collection Underway - Reminders and Tips

We are now well into the new SOR Fiscal year, which began 10/1/22. This also marked the start of the new SOR III grant period. We wanted to share a few TA tips from our 9/21 Kickoff Training to remind everyone of the transition to SOR III in terms of GPRA completions.

Here are important materials on our website to support the transition from SOR II to SOR III. They are housed in the New to the GPRA Section. Here are direct links:

We welcome any follow-up questions that you may have. Reach out to us at SORsupport@omni.org or fill out the TA Request form on our website.

https://www.ecfr.gov/current/title-2/subtitle-A/chapter-II/part-200#200.112 Per 2 C.F.R. § 200.112-1113 The Federal awarding agency must establish conflict of interest policies for Federal awards. The non-Federal entity must disclose in writing any potential conflict of interest to the Federal awarding agency or pass-through entity in accordance with applicable Federal awarding agency policy. Failure to adhere to these statues will result in immediate termination of funding.

Virginia’s State Opioid Response (SOR) grant is awarded at the discretion of DBHDS and SAMHSA. All recipients of SOR funding supports evidence-based prevention, treatment and recovery services to address opioid and stimulant misuse and use disorders, including for cocaine and methamphetamine. The SOR grant is not intended to be utilized as a long-term or permanent funding source. All SOR proposals must include a realistic plan for financial sustainability beyond the grant period.